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Passive smoking may be implicated in the development of cardiovascular disease (CVD) in children because of their partially
developed physiological systems. The aim of the present systematic paper is to investigate whether passive smoking is associated
with factors that inﬂuence the development of CVD in children. Data sources included Medline, Cochrane Library, Cumulative
Index to Nursing & Allied Health (CINAHL) research database, Google Scholar, Excerpta Medica database (EMBASE), the 2006
Oﬃce of the Surgeon General’s report, and the 2005 report from the California Environmental Protection Agency. We identiﬁed
a total of 42 relevant articles (i.e., 30 reviews and 12 observational). Results revealed that passive smoking may be implicated in
deteriorating cardiovascular status in children in terms of unfavorable high-density lipoprotein levels and deteriorated vascular
function.
1.Introduction
Active smoking and disease is a research area investigated
for many decades. The ﬁrst ever case-control studies which
revealed a strong association between active smoking
and lung cancer were conducted in Nazi Germany in
1939 and 1943 [1]. Many other studies, thereafter, have
explored the eﬀects of tobacco smoke on human health.
It is now an accepted fact that smoking is responsible for
the development of chronic diseases as well as increased
morbidity and mortality [2].
During the last decades research has also expanded in
the area of passive smoking (PS) and its eﬀects on aspects
of human health. The ﬁrst conclusive evidence on the danger
of PS arose in 1981 from a study showing that nonsmoking
Japanese women married to men who smoked had an
increased risk for lung cancer [3]. Since then, a vast number
of studies have appeared investigating the unfavorable eﬀects
of PS. In line with active smoking, it is now generally
accepted that PS leads to increased prevalence of various
cardiovascular diseases [4] and increases the risk of death
by at least 20% [5]. More importantly, recent method-
ologically robust data from nonsmoking adults have shown
that PS compromises health not only when individuals
are exposed frequently for prolonged periods of time—as
initially thought—but also after a single brief exposure [6–
10]. This novel evidence clearly shows that PS may have a
substantive role in the development of chronic diseases [11].
Despite the recent measures adopted in diﬀerent coun-
tries toeliminate indoor smoking, 700 million childrenglob-
ally are still exposed to environmental tobacco smoke [12]
while the smoking epidemic continues to increase worldwide
[13]. Given that tobacco smoke contains chemicals charac-
terized as carcinogenic (e.g., benzene, chlorinated dioxins,
and benzo[a]pyrene) and have adverse health consequences
on the cardiovascular (e.g., arsenic) and respiratory (e.g.,
acetaldehyde) systems in adults [14], the physiologically
immature children may be more vulnerable to damage as
a result of PS exposure because of their partially developed
or compromised cardiovascular, endocrine, and immune
systems. For these reasons, we conducted a systematic review2 Cardiology Research and Practice
of the available literature to investigate the evidence regard-
ing PS and its association with factors that inﬂuence the
development of cardiovascular disease (CVD) in children.
2. Methods
Five databases [Medline, Cochrane Library, Cumulative
Index to Nursing & Allied Health (CINAHL) research
database, Google Scholar, Excerpta Medica database
(EMBASE)], the 2006 report on second hand smoke by the
Oﬃce of the Surgeon General [4], and the 2005 report by
the California Environmental Protection Agency [15]w e r e
searched to identify publications from 1975 to April 2009 in
English regarding PS and cardiovascular disease in children
(<18 years old). The Medical Subject Heading (MeSH) terms
“PS,” “second hand smoking,” “environmental tobacco
smoking”, “maternal smoking,” and “parental smoking”,
were searched in combination with “obesity”, “diabetes,”
“hypertension,” “blood pressure,” “cholesterol,” “lipids,”
and “cardiovascular disease.” Editorials and conference
proceedings were excluded. If the abstract did not provide
suﬃcient information for this process, then the full-text
manuscript was examined. The cited articles of the selected
papers were also searched manually in order to identify
relevant studies not identiﬁed in the original search. A ﬂow
diagram of the studies identiﬁed from databases and the
combination of key words used to identify the observational
studies included in the present paper in Figure 1.
3. Results
We identiﬁed a total of 77 articles, from which only 42 were
relevant; of which 30 were reviews and 12 were observational
studies and thus included in the present paper. Table 1
depictstheresultsofeachstudyincludedinthepresentpaper
(n = 12).
From the results of the present paper it appears that
newborn children exposed to PS at home are more likely to
be overweight and obese, particularly when exposed during
the ﬁrst three years of their life [16]. It was also found that
PS is associated with deteriorated blood lipids proﬁles in
children, particularly lower high-density lipoprotein which
has been a consistent ﬁnding in most studies [17–21]. A
randomized controlled trial (RCT) also revealed that in
passive smokers the rate of factors associated with the
development of CVD, such as body weight, cholesterol, and
triglycerides, was higher than that in non-PS smokers [22].
PS in children has also been examined in relation
to vascular biological parameters. PS appears to directly
aﬀect endothelial function in children via a dose-dependent
decrease in the bioavailability of nitric oxide [23]. Two
randomized controlled studies (RCTs) found that children
exposed to PS have also reduced aortic elasticity possibly
via the direct eﬀects of PS on the mechanical properties of
the arteries (e.g., impaired nitric oxide production, platelet
activation, or adrenalin levels) [23, 24].
The eﬀects of exposure to PS during pregnancy with
regards to risks factors associated with CVD were investi-
gated in two separate studies. Results revealed a signiﬁcantly
higher concentration of cotinine in children due to exposure
to PS from the mother during pregnancy [25] and that PS
increased oxidative stress in cord blood [26]. The eﬀects of
maternal PS exposure on absolute red blood counts (RBC)
were assessed in newborn infants of 55 mothers exposed and
31 not exposed to PS during the last trimester; data revealed
that the counts of absolute nucleated RBCs were signiﬁcantly
elevated in the PS exposed group. Table 1 depicts the results
ofallstudiesidentiﬁedinrelationtoPSandCVDinchildren.
4. Discussion
The present systematic review investigated the eﬀects of PS
on CVD (classical risk factors and vascular function) in
children. The results reveal that PS may be implicated in
deteriorating cardiovascular status in terms of unfavorable
high-density lipoprotein levels and deteriorated vascular
function, whereas the mechanisms by which PS negatively
aﬀect the cardiovascular status of children (in terms of
classical CVD risk factors) have yet to be elucidated. Perhaps,
the signiﬁcant decrease in cardiorespiratory function, as a
result of smoking/PS, leads to a decrease in physical activity
in children which may then have a signiﬁcant unfavorable
impact on body fat and cholesterol levels. This is supported
by a vast amount of evidence demonstrating that physical
inactivity results in worse proﬁlein classical CVD risk factors
in both healthy and diseased populations [28–30].
Two RCT studies [23, 24] have consistently revealed
that children exposed to PS have reduced aortic elasticity.
The signiﬁcant alterations in vascular biological mechanisms
from an early age may lead to a deteriorated health status
of children exposed to PS, given that vascular dysfunc-
tion precedes atherosclerosis and leads to increased CVD
mortality [31, 32]. PS appears to directly aﬀect endothelial
function in children via a dose-dependent decrease in nitric
oxide [23], a mechanism preceding atherosclerosis [31].
Vascular endothelial dysfunction has been implicated in
the progression of atherosclerosis and cardiovascular event
rates; hence, its assessment may provide pivotal information,
particularly given that it may detect “silent” clinical mani-
festations leading to ischaemia. This is the reason why this
assessmentisconsistentlyusedinresearchandclinicalsetting
for both prognostic and diagnostic means. Nitric oxide is a
vasoactive factor responsible for dilation of the vessels; the
drop in exhaled nitric oxide levels within the ﬁrst minutes
of PS may be caused by decreased production of nitric
oxide synthase through a negative feedback mechanism,
given the high concentrations of nitrogen oxides inherent in
tobacco smoke [33]. Possible other mechanisms comprise an
increased breakdown of nitric oxide by PS oxidants or a PS-
induced accelerated uptake of nitric oxide [34].
Data from adults have shown that the PS-induced
changes in lipoprotein oxidization generate various eﬀects
in the vessel wall [35]. Animal experiments have shown a
synergistic eﬀect between PS and lipoprotein that inﬂuenceCardiology Research and Practice 3
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Figure 1: Articles identiﬁed and included in systematic review.
the oxidation of lipoprotein in the vessel wall [36]. It is also
important to note that polycyclic aromatic hydrocarbons—
byproducts of the incomplete combustion of organic mate-
rial inherent in PS—bind to lipoprotein subfractions and
can be integrated into the atheromatic plaques promoting
the proliferation of vascular cells and plaque progression
[35].
Elevated absolute nucleated RBCs count in the neonate,
as observed by Cochran-Black et al. [27], is a marker of fetal
hypoxia [15].Periodsofhypoxiamaystimulatebonemarrow
to increase the hematocrit possibly in concert with a more
rapid smoke-induced RBC turnover. The ﬁndings from this
study suggest that maternal PS exposure has similar eﬀects
on the fetus as active maternal smoking.
It is of great clinical importance to explore the associa-
tions between PS and either pregnancy or early childhood.
Clearly, PS has well-established adverse health eﬀects in
children [37, 38] whereas the mechanisms by which PS
aﬀects the fetus may be diﬀerent to those that aﬀect the
child or adolescent; the deterioration in cardiorespiratory
andimmunesystemaswellasthetoxicsubstancesintobacco
smoke are currently the main suggested mechanisms.
Through this systematic review of the current available data,
it appears that paternal PS promotes the development of
CVD. However, we have previously demonstrated—by using
a robust methodological design—that in young adults, even
the normal PS exposures (similar to those seen in public
places and houses) may signiﬁcantly compromise health
parameters [6–8]. Minimizing children’s exposure to PS
should therefore be amongst the main aims of interventional
studiesinordertoraisepublicawarenessandimproveparent
education and counseling.
There are several limitations in the methodological
designs of studies conducting research on the eﬀects of PS
on children’s health. Most of the studies do not take into
account very important confounding factors such as the
environmental ones (e.g., exposure to other carcinogenic
substances) or maternal diet and obesity that may indeed
result in increasing CVD prevalence in children. Most
importantly, the adopted designs allow only for cross-
sectional comparisons, in which the directionality and
causality of associations cannot be clearly justiﬁed. Also, the
vast majority of published studies justify PS on self-reports
withoutanobjectivemeasurementofexposure(e.g.,cotinine
levels). Moreover, it may be possible that PS has indirect
eﬀects on CVD outcomes in children, via its immunosup-
pressive capabilities [37]. For example, it is estimated that
PS is equivalent to smoking ∼100 cigarettes per year. This
number, however, ranges according to the smoking habits of
parents [39]. It has been found that even 30 minutes of PS
signiﬁcantlydeterioratecardiovascularoutcomessimilarlyto
smoking [40]. Hence, it seems reasonable to suggest that the
physiologically undeveloped systems of fetus/children may
be more susceptible to damage from the toxic eﬀects of PS,
particularly given the fact that the eﬀects of PS may occur at
v e r yl o wl e v e l so fe x p o s u r e[ 41].4 Cardiology Research and Practice
Table 1: The eﬀects of PS on CVD.
Author [reference] Design Participants Results
Apfelbacher et al. [16] Cohort cross-sectional 35,434 children (50.9% boys),
5–7 years old
PS was a predictor of being overweight and/or
obese
¨ Ohrig et al. [22]R C T 3495 children (age 6.5 ±2 years) In passive smokers the rates of body weight,
cholesterol, and triglycerides were higher
Hargrave et al. [25] Controlled Clinical trial Children-speciﬁc numbers not
mentioned
Signiﬁcantly higher concentration of cotinine
found in children due to exposure in PS from
the mother rather than that from father/friends
Aycicek and Ipek [26] Clinical trial Mothers giving birth PS increased oxidative stress in cord blood
Kallio et al. [23]R C T 441 children (8–11 years) PS impairs endothelial function in children
Kallio et al. [24]R C T 386 children (11 years) PS impairs aortic elasticity
Neufeld et al. [19] Cross-sectional (pilot scale) 161 children and adolescence
(2–18 years)
High density lipoprotein was signiﬁcantly
lower in passive smokers. PS may increase the
risk proﬁle for later atherosclerosis
Moskowitz et al. [17] Longitudinal
105 PS twin pairs and 111
non-PS twin pairs (all
preadolescent children)
HDL was lower in PS children. Also, signiﬁcant
adverse alterations were already present in
lipoprotein proﬁles in twin exposed to PS
Moskowitz et al. [18] Cohort analytic 408 twins (11 years at baseline)
HDL is signiﬁcantly lower in passive smokers.
White males that have a history of higher CVD,
or higher weight, and/or blood pressure may
be at increased risk for developing premature
CVD
Feldman et al. [20] Cross-sectional Healthy adolescents Lower high density lipoprotein in passive
smokers
Is ¸can et al. [21] Cross-sectional 194 healthy children (4–14 years) Total cholesterol, low-density lipoprotein were
signiﬁcantly higher in passive smokers
Cochran-Black et al. [27] Cross-sectional 55 mothers exposed to PS and 31
not exposed to PS
No signiﬁcant diﬀerences in counts for total
red blood cells, white blood cells, platelets, and
lymphocytes. Absolute nucleated RBCs
signiﬁcantly elevated in the PS exposed group.
The fact that the majority of the available published
paper on this research area were reviews rather than
originalresearchinvestigationsdemonstratesthediﬃcultyof
performing research on PS and CVD in children. We have
performed a systematic review of the literature in order to be
objectiveratherthanassumecausalityandreportonlyresults
that favor directionality of associations, which appears to be
the case in many published papers. Based on the available
ﬁndings, interventions that target the cessation of parental
smoking at home and preconception parental smoking, are
necessary. Despite that indoor PS has been banned in many
countries, PS at home is the most diﬃcult to control and at
the moment pulled data from systematic study reveal that
interventions to reduce exposure in children are ineﬀective
[42].
The ﬁndings of this systematic paper are particularly
timely given the emerging experimental evidence on the
adverse eﬀects of passive smoking on health [6–8], as well as
the shifting global smoking patterns, with an estimated 930
millionoftheworld’s1.1billionsmokerslivingindeveloping
countries, that also demonstrate increasing smoking rates
amongst young individuals [30, 43]. The ﬁndings of this
paper indicate that public health preventive actions toward
minimizing the exposure of children to PS should aim not
only at suppressing tobacco use, but should also target family
inﬂuence as attitudes that reinforce smoking behaviors and
increase the exposure of children to PS.
5. Conclusions
We conclude that the current available data reveal that
PS in children is linked with deteriorated lipid proﬁle
and vascular function whereas data for maternal smoking
(during pregnancy and PS after birth) are still inconclusive
mainlyduetodesignconstrainsandlackofadjustingbecause
of important confounding factors.
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